DEA, FDA on Adderall Shortage: Urge Drugmakers to Boost Production
The DEA and FDA addressed the Adderall shortage, urging drugmakers to boost production of stimulants and providers to develop alternative ADHD treatments.
Source: additudemag.com
Stay updated with breaking news from Webmd John Whyte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The DEA and FDA addressed the Adderall shortage, urging drugmakers to boost production of stimulants and providers to develop alternative ADHD treatments.
The Adderall shortage was blamed, in part, on overuse of stimulant medication by ADHD patients by the FDA commissioner.
AI’s potential depends on how it’s used, Robert Califf, MD, said. “It could be used for tremendous gain or it could be used for tremendous harm.”
New advisory calls on public and private stakeholders and community partners to address the root causes of burnout among healthcare workers.